Analysis of computer tomographic image: skeleto-muscle index as a criterion of sarcopenia in patients with patients with patients

Authors

DOI:

https://doi.org/10.15587/2519-4798.2019.155668

Keywords:

pancreatic cancer, sarcopenia, computed tomography, skeletal muscle index, somatotype

Abstract

Aim of the study. The study of the possibility and informativeness of the detection of sarcopenia in a patient with pancreatic cancer (PC) by post-processing obtained using computed tomography (CT) images.

Materials and methods. A total of 108 patients with obstructive jaundice syndrome (probably of tumor etiology, and later diagnosed with pancreas cancer) were studied using the «Activion 16» spiral tomograph (Toshiba Medical Systems Corporation) according to a common protocol. The control group consisted of 60 patients aged from 22 to 74 years. We determined sarcopenia criteria on CT images: musculoskeletal L3 index (MSI) as the ratio of the area indicator of skeletal muscle in the body to the level L3 square growth patient. The somatotype index (SI) was determined by the formula: SI = BL x 100 / TSCH, where BL is the body length, TSCH is the transverse size of the chest, measurement in centimeters.

Results. Based on media values at the L3 level, sarcopenia was generally detected in 85.18 % of patients with pancreas cancer. Sarcopenia was observed in 100 % of patients with a dolichomorphic type, in 87.8 % of patients with a mesomorphic type, and in 65.5 % of patients with a brachiomorphic type of somatotype. Sarcopenia based on SMI at the L3 level is set in 85.2 % of patients with pancreas cancer: 47.8±4.3 cm² / m² for men, 36.2±4.1 cm² / m² for women, 58.4±3 6 cm² / m² and 44.2±3.5 cm² / m² for conditionally healthy men and women, respectively (p<0.01). The reliable differences of SMI according to gender were established in conditionally healthy men and women suffering from pancreatic cancer with inaccurate differences in BMI. In patients, the statistically significant difference of SMI (p = 0.001), corresponds to the various distribution of fatty mass in the body structure, was accompanied by statistical misleading differences in BMI.

Findings. CT as a standard method of diagnosis of pancreatic cancer and inflammatory diseases of the pancreas by calculating the SMI allows evaluating the degree of sarcopenia. SMI is more informative and personalized indicators to assess body composition than the standard used BMI as CT allows differentiation of muscle and fat components in the composition of the human body and to quantify

Author Biography

Elena Kolesnik, National Cancer Institute Lomanosova str., 33/43, Kyiv, Ukraine, 03022

MD, Professor

References

  1. Cancer in Ukraine, 2014–2015 (2017). Bulletin of the National Chancellery-the Register of Ukraine No. 16. Kyiv, 173.
  2. Dewys, W. D., Begg, C., Lavin, P. T., Band, P. R., Bennett, J. M., Bertino, J. R. et. al. (1980). Prognostic effect of weight loss prior tochemotherapy in cancer patients. The American Journal of Medicine, 69 (4), 491–497. doi: http://doi.org/10.1016/s0149-2918(05)80001-3
  3. Tisdale, M. J. (2009). Mechanisms of Cancer Cachexia. Physiological Reviews, 89 (2), 381–410. doi: http://doi.org/10.1152/physrev.00016.2008
  4. Anker, S. D., Morley, J. E., von Haehling, S. (2016). Welcome to the ICD-10 code for sarcopenia. Journal of Cachexia, Sarcopenia and Muscle, 7 (5), 512–514. doi: http://doi.org/10.1002/jcsm.12147
  5. Lyadov, V. K., Bulanova, E. A., Seryakov, A. P. (2012). Sarcophenia as a leading component of cancerous cachexia syndrome. Russian Journal of Gastroenterology, Hepatology, Coloproctology, 1, 4–8.
  6. Muscaritoli, M., Lucia, S., Molfino, A. (2013). Sarcopenia in critically ill patients: the new pandemic. Minerva Anestesiologica, 79 (7), 717.
  7. Kamimoto, L. A., Easton, A. N., Maurice, E., Husten, C. G., Macera, C. A. (1999). Surveillance for Five Health Risks Among Older Adults – United States, 1993–1997. CDC MMWR Surveillance Summaries, 48, 89–130.
  8. Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I., Bruera, E., Fainsinger, R. L. et. al. (2011). Definition and classification of cancer cachexia: an international consensus. The Lancet Oncology, 12 (5), 489–495. doi: http://doi.org/10.1016/s1470-2045(10)70218-7
  9. Kolotyolov, N. N. (2012). Water – a new point of view on the subject of radiation diagnostics. Radiation diagnostics, radiation therapy, 1, 63–69.
  10. Morley, J. E., Thomas, D. R., Wilson, M.-M. G. (2006). Cachexia: pathophysiology and clinical relevance. The American Journal of Clinical Nutrition, 83 (4), 735–743. doi: http://doi.org/10.1093/ajcn/83.4.735
  11. Kolotilov, N. N. (2017). Intellectualization of the organs' morphometry: golden section. Radiation Diagnostics, Radiation Therapy, 4, 80–82.
  12. Gordienko, K. P. (2004). Possibilities of X-ray computer and magnetic resonance imaging in differential diagnosis of pancreatic tumors. Radiation diagnostics, radiation therapy, 4, 38–42.
  13. Rosenfeld, L. G., Makomela, N. M., Sinitsky, S. I., Kolotilov, N. N., Ogir, A. S. (2006). Possibilities of post-processing of diagnostic CT and MRI images on a personal computer. Ukrainian medical journal, 6, 69–73.
  14. Ternovaya, K. S., Rosenfeld, L. G., Kolotyolov, N. N. (1990). Principles for solving medical problems. Kyiv: Science thought, 220.
  15. Nikolayev, V. G., Nikolaev, N. N., Sindeeva, L. V. et. al. (2007). Anthropological examination in clinical practice. Krasnoyarsk: Verso, 172.
  16. Baracos, V. E., Reiman, T., Mourtzakis, M., Gioulbasanis, I., Antoun, S. (2010). Body composition in patients with non−small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis. The American Journal of Clinical Nutrition, 91 (4), 1133S–1137S. doi: http://doi.org/10.3945/ajcn.2010.28608c
  17. Prado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., Baracos, V. E. (2008). Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. The Lancet Oncology, 9 (7), 629–635. doi: http://doi.org/10.1016/s1470-2045(08)70153-0
  18. Tan, B. H. L., Birdsell, L. A., Martin, L., Baracos, V. E., Fearon, K. C. H. (2009). Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer. Clinical Cancer Research, 15 (22), 6973–6979. doi: http://doi.org/10.1158/1078-0432.ccr-09-1525
  19. Petri, A., Sabin, K.; Leonova, V. P. (Ed.) (2015). Visual medical statistics. Moscow: GEOTAR-MEDIA, 216.
  20. Lyadov, V. K., Bulanova, E. A., Sinitsyn, V. E. (2012). Possibilities of CT in detecting sarcopenia in patients with tumorous and inflammatory diseases of the pancreas. Diagnostic and Interventional Radiology, 1, 13–18.

Published

2019-02-01

How to Cite

Zabudska, L., & Kolesnik, E. (2019). Analysis of computer tomographic image: skeleto-muscle index as a criterion of sarcopenia in patients with patients with patients. ScienceRise: Medical Science, (1 (28), 31–36. https://doi.org/10.15587/2519-4798.2019.155668

Issue

Section

Medical Science